These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 14572327)

  • 1. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part II: Archival calibration.
    Marple VA; Olson BA; Santhanakrishnan K; Mitchell JP; Murray SC; Hudson-Curtis BL
    J Aerosol Med; 2003; 16(3):301-24. PubMed ID: 14572327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation pharmaceutical impactor: a new impactor for pharmaceutical inhaler testing. Part III. extension of archival calibration to 15 L/min.
    Marple VA; Olson BA; Santhanakrishnan K; Roberts DL; Mitchell JP; Hudson-Curtis BL
    J Aerosol Med; 2004; 17(4):335-43. PubMed ID: 15699634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Next generation pharmaceutical impactor (a new impactor for pharmaceutical inhaler testing). Part I: Design.
    Marple VA; Roberts DL; Romay FJ; Miller NC; Truman KG; Van Oort M; Olsson B; Holroyd MJ; Mitchell JP; Hochrainer D
    J Aerosol Med; 2003; 16(3):283-99. PubMed ID: 14572326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of stage mensuration data to the performance of new and used cascade impactors.
    Roberts DL; Romay FJ
    J Aerosol Med; 2005; 18(4):396-413. PubMed ID: 16379616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
    Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
    AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Aerodynamic Particle Size Distribution Between a Next Generation Impactor and a Cascade Impactor at a Range of Flow Rates.
    Yoshida H; Kuwana A; Shibata H; Izutsu KI; Goda Y
    AAPS PharmSciTech; 2017 Apr; 18(3):646-653. PubMed ID: 27173989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A methodology to study impactor particle reentrainment and a proposed stage coating for the NGI.
    Rissler J; Asking L; Dreyer JK
    J Aerosol Med Pulm Drug Deliv; 2009 Dec; 22(4):309-16. PubMed ID: 19415989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of Aerodynamic Particle Size Distribution of Orally Inhaled Products by Cascade Impactor: How to Let the Product Specification Drive the Quality Requirements of the Cascade Impactor.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2019 Jan; 20(2):57. PubMed ID: 30623259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of delivery characteristics from a combination metered-dose inhaler using the Andersen cascade impactor and the next generation pharmaceutical impactor.
    Guo C; Gillespie SR; Kauffman J; Doub WH
    J Pharm Sci; 2008 Aug; 97(8):3321-34. PubMed ID: 17932959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations.
    Mitchell JP; Nagel MW
    J Aerosol Med; 2003; 16(4):341-77. PubMed ID: 14977427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aerodynamic characteristics of nebulized terbutaline sulphate using the Andersen Cascade Impactor compared to the Next Generation Impactor.
    Abdelrahim ME
    Pharm Dev Technol; 2011 Apr; 16(2):137-45. PubMed ID: 20100034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multi-laboratory in Vitro Study to Compare Data from Abbreviated and Pharmacopeial Impactor Measurements for Orally Inhaled Products: a Report of the European Aerosol Group (EPAG).
    Nichols SC; Mitchell JP; Sandell D; Andersson PU; Fischer M; Howald M; Pengilley R; Krüger P
    AAPS PharmSciTech; 2016 Dec; 17(6):1383-1392. PubMed ID: 26762338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of nonideal cascade impactor stage collection efficiency curves on the interpretation of the size of inhaler-generated aerosols.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2013 Jun; 14(2):497-510. PubMed ID: 23508617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cascade impactor practice for a high dose dry powder inhaler at 90 L/min: NGI versus modified 6-stage and 8-stage ACI.
    Kamiya A; Sakagami M; Byron PR
    J Pharm Sci; 2009 Mar; 98(3):1028-39. PubMed ID: 18661538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Abbreviated Impactor Measurements (AIM) and Efficient Data Analysis (EDA) for Dry Powder Inhalers (DPIs) Against the Full-Resolution Next Generation Impactor (NGI).
    Mohan M; Lee S; Guo C; Peri SP; Doub WH
    AAPS PharmSciTech; 2017 Jul; 18(5):1585-1594. PubMed ID: 27624069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of nebulizer droplet size distribution: a method based on impactor refrigeration.
    Berg E; Svensson JO; Asking L
    J Aerosol Med; 2007; 20(2):97-104. PubMed ID: 17536948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceptance Testing of Used Cascade Impactor Stages Based on Pressure Drop Measurements in a Flow System Managed with a Critical Flow Venturi: Part II-Quantification of the Test Uncertainty Ratio for Pass/Fail Decision-Making under Pharmacopeial Constraints.
    Roberts DL
    J Aerosol Med Pulm Drug Deliv; 2024 Feb; 37(1):11-18. PubMed ID: 38019194
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of the next generation pharmaceutical impactor for particle size distribution measurements of live viral aerosol vaccines.
    Leung K; Louca E; Gray M; Tipples G; Coates AL
    J Aerosol Med; 2005; 18(4):414-26. PubMed ID: 16379617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines.
    Wong W; Crapper J; Chan HK; Traini D; Young PM
    J Pharm Biomed Anal; 2010 Mar; 51(4):853-7. PubMed ID: 19932579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tubing deposition, breathing pattern, and temperature on aerosol mass distribution measured by cascade impactor.
    Gurses BK; Smaldone GC
    J Aerosol Med; 2003; 16(4):387-94. PubMed ID: 14977429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.